Steven L. Barriere, PharmD, FIDSA, FCCP, FIDP
Dr. Barriere has the notable distinction of being one of the six founding members of SIDP, serving on the original Board of Directors, and as SIDP President from 1996-1997. He has also served as chair or a contributing member of numerous SIDP committees for over 25 years. He was a pioneer in infectious diseases pharmacy as one of the first PharmDs to develop the role of the “ID Pharmacist” in 1973. He developed clinical clerkships and pharmacy practice resident rotations in infectious diseases, and trained 7 PharmDs in ID fellowship programs at two different institutions. Following his role in clinical infectious diseases pharmacy, he held high level leadership positions in the pharmaceutical industry, focused in the area of antibiotic development. He also served as Director of Clinical Affairs at Gilead Sciences from 1997 to 2001, where he was responsible for directing staff functioning in corporate product safety and medical information groups. His final position was at Theravance Biopharma Inc. as Vice-President, Clinical & Medical Affairs, where he was responsible for oversight of anti-infective clinical development resulting in the approvals of telavancin for serious Staphylococcal infections. He is also a prolific scientist and scholar, having published more than 150 peer-reviewed publications, books and book chapters that have greatly contributed to the optimization of antimicrobial use. Dr. Barriere retired in 2015.
David T. Bearden, PharmD, FIDP
Dr. Bearden is currently a Clinical Professor and Chair of the Department of Pharmacy Practice at Oregon State University. He has made a tremendous impact on SIDP, having served 5 consecutive years as part of the SIDP Board of Directors from 2011 to 2015. He has also been an active member of numerous committees for 19 years. As SIDP president, he helped to advance the Society’s collaborations across the broader field of antimicrobial stewardship and infectious diseases, with regular strategic meetings with key national and international leaders in medicine, pharmacy, and public health. Notably, Dr. Bearden represented SIDP at the White House One Health Forum on Antibiotic Stewardship in Washington DC in June 2015. Dr. Bearden is also a gifted and highly effective teacher. His educational role has included didactic teaching of PharmD students, as well as experiential teaching of infectious diseases residents and fellows. Dr. Bearden also maintains an active research program, focused on the impact of obesity on antimicrobial pharmacokinetics and the impact of bacterial resistance on antimicrobial usage. His publications collectively have been cited more than 1400 times.
John A. Bosso, PharmD, FIDSA, FCCP, FIDP
Dr. Bosso is currently Professor Emeritus in the Department of Clinical Pharmacy and Outcomes Science in the College of Pharmacy and Professor of Medicine in the Division of Infectious Diseases in the College of Medicine at the Medical University of South Carolina in Charleston, SC. As a founding member of SIDP, Dr. Bosso implemented his collaborative vision to formally bring together infectious diseases pharmacists. He served as SIDP President from 1993-1994 and has held other leadership positions within the Society. He is also a founding member and current president of Making a Difference in Infectious Diseases, an internationally recognized non-profit organization dedicated to multidisciplinary continuing professional education in the area of infectious diseases prevention and treatment and antimicrobial stewardship. Dr. Bosso has been a clinical specialist in pediatric and adult infectious diseases for over 40 years and has trained numerous infectious diseases fellows and residents. His research has focused on anti-infective pharmacokinetics, pharmacodynamics, and efficacy in both pediatric and adult patients, as well as relationship between antibiotic use and resistance. He has an impressive scholarly record, having published more than 140 peer-reviewed papers and numerous book chapters and has received over 100 research grants.
Douglas N. Fish, PharmD, FCCM, FCCP, BCCCP, BCPS (AQ-ID), FIDP
Dr. Fish is currently a Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and a Clinical Pharmacy Specialist at the University of Colorado Hospital. He has been a continuous member of SIDP for 25 years and has served in every level of leadership within the society, including President from 2003 to 2004. Dr. Fish has contributed to the growth and legacy of SIDP through numerous initiatives, including society infrastructure improvements, membership expansion, and long-term economic planning. In the area of education, Dr. Fish has directed and taught courses related to infectious diseases pharmacotherapy, given numerous invited presentations, and developed and served as the Residency Program Director for ASHP-accredited PGY2 Infectious Diseases Pharmacy Residencies that have trained a dozen residents. He has won over two dozen teaching awards, including the 2017 American College of Clinical Pharmacy Education Award for sustained and outstanding contributions to clinical pharmacy education. Finally, Dr. Fish has been highly active in research and scholarship and is nationally recognized as an expert in surgical prophylaxis, antimicrobial PK/PD, and use of antimicrobials in critically ill patients. He has over 150 peer-reviewed publications and has served as a member of expert panels for several published consensus guidelines related to infectious diseases.
Jason C. Gallagher, PharmD, FCCP, FIDSA, BCPS, FIDPDr. Gallagher is currently a Clinical Professor at Temple University and Clinical Infectious Diseases Specialist at Temple University Hospital. Dr. Gallagher has served SIDP in many roles, including President from 2015-2016. His contributions helped SIDP achieve significant milestones, including development of the long-term care stewardship certificate program, expansion of SIDP on social media, and publication of position statements on the role of the ID pharmacist. Dr. Gallagher also spearheaded the development of the Society of Infectious Disease Education Center, which has gone on to produce and archive continuing education programs for SIDP members. Dr. Gallagher has also made an impact on countless students and ID residents through his coordination of the integrated ID pharmacotherapy course at Temple and his service as the Director of a PGY2 residency program. He also teaches antimicrobial stewardship to pharmacists internationally, as part of the Caribbean Public Health Agency. Dr. Gallagher is also a respected scholar, having published numerous book chapters and original research articles. His book, “Antibiotics Simplified”, co-authored with Conan MacDougall, is now in its fourth edition.
Paul O. Gubbins, PharmD, FCCP, FIDP
Dr. Gubbins is currently an Associate Dean, Vice-Chair, and Professor at the University of Missouri-Kansas City School of Pharmacy at Missouri State University. In his 26 years of SIDP membership, he has served 19 terms of membership on a variety of committees and task forces, including several leadership positions. During his term as SIDP President from 2010-2011, Dr. Gubbins launched the SIDP Antimicrobial Stewardship Program and worked tirelessly with the Board of Directors to ensure its financial and operational stability. He also developed the first catalog of searchable ID training programs for the Society and co-authored publications on behalf of SIDP. In addition to his contributions to SIDP, Dr. Gubbins is an outstanding educator and scholar. He has provided 26 years of didactic education in infectious diseases to students at two universities and 21 years of experiential education on an interprofessional ID consult service to students and residents. He also developed and led an ID Research Fellowship that has successfully graduated three fellows. Dr. Gubbins is an internationally recognized expert in fungal diseases and antifungal pharmacology. He has co-authored more than 80 peer-reviewed papers and book chapters and has received multiple distinguished research awards.
John F. Mohr III, PharmD, FIDP
Dr. Mohr is currently the Senior Vice President for Clinical and Medical Affairs at scPharmaceuticals, Inc. and President and Founder of Medical Affairs Strategic Solutions, LLC. Dr. Mohr began his infectious diseases career as a clinical pharmacist and academic researcher and ultimately leveraged these foundational experiences to become a highly successful and influential leader in pharmaceutical industry. His expertise in antimicrobial PK/PD and his tremendous leadership ability have contributed to the development and launch of several new antibiotics, including daptomycin, fidaxomicin, and ceftolozane-tazobactam. He has also lobbied for legislation in support of new antimicrobial development and has served as an influential educator in the field. He has been a dedicated and passionate leader for SIDP for many years. He has served in several leadership positions, including two terms on the Board of Directors and multiple committee chair positions. His valuable industry perspective has influenced SIDP’s approach for fundraising, as well as strategic planning.